Association of single nucleotide polymorphisms with renal cell carcinoma in Algerian population

African Journal of Urology

Table 2 Genotypic and allelic frequencies of 14 tag-SNPs in the RCC cases and controls

	P1^a	OR (95% CI)^a	P2^a	HWE
VEGF
rs2010963	0.775	1.16 (0.77–1.73)	0.47	0.51
rs699947	0.416	1.31 (0.87–1.95)	0.21	0.91
rs833061	0.475	1.27 (0.85–1.89)	0.26	0.96
VHL
rs1642742	0.663	0.88 (0.59–1.31)	0.61	0.82
rs779805	0.691	0.88 (0.59–1.32)	0.61	0.88
FAF1
rs4381241	0.417	1.27 (0.85–1.89)	0.26	0.40
rs67311347	0.086	1.49 (0.99–2.25)	0.05	0.20
LRRIQ4
rs10936602	0.248	0.69 (0.39–1.20)	0.21	0.70
RHOBTB2
rs2241261	0.604	0.89 (0.60–1.33)	0.61	0.91
OBFC1
rs11813268	0.869	0.89 (0.59–1.34)	0.60	0.07
ATM
rs1800057	0.034	10.93 (1.35–88.31)	0.01	0.53
DPF3
rs49030664	0.979	1.04 (0.69–1.55)	0.91	0.93
ALDH9A1
rs3845536	0.015	0.62 (0.41–0.93)	0.02	0.76
EPAS1
rs7579899	0.977	1.02 (0.69–1.52)	0.91	0.64

^aχ² test or Fisher’s exact test. P1: Genotypic frequencies p value. P2: Allelic frequencies p value. OR: Odds Ratio. CI: Confidence Interval